Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Locus Control Region | 7 | 2014 | 8 | 2.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 6 | 2015 | 26 | 2.060 |
Why?
|
| Embryonic Stem Cells | 4 | 2014 | 55 | 1.310 |
Why?
|
| Asthma | 6 | 2022 | 416 | 1.150 |
Why?
|
| Cell Differentiation | 5 | 2014 | 638 | 1.040 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 1070 | 0.880 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 386 | 0.740 |
Why?
|
| Nasal Polyps | 1 | 2021 | 4 | 0.730 |
Why?
|
| Rhinitis | 1 | 2021 | 18 | 0.710 |
Why?
|
| Sinusitis | 1 | 2021 | 20 | 0.710 |
Why?
|
| Anti-Asthmatic Agents | 4 | 2022 | 44 | 0.680 |
Why?
|
| Thymus Gland | 5 | 2015 | 76 | 0.640 |
Why?
|
| Mice, Transgenic | 9 | 2015 | 665 | 0.550 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2013 | 91 | 0.520 |
Why?
|
| Genes, T-Cell Receptor alpha | 2 | 2007 | 2 | 0.510 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2011 | 161 | 0.500 |
Why?
|
| Genetic Loci | 1 | 2015 | 104 | 0.450 |
Why?
|
| Cytological Techniques | 1 | 2014 | 14 | 0.440 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 47 | 0.430 |
Why?
|
| DNA-Binding Proteins | 3 | 2007 | 561 | 0.380 |
Why?
|
| Cell Lineage | 1 | 2013 | 104 | 0.380 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 21 | 0.340 |
Why?
|
| Mice | 10 | 2014 | 6644 | 0.330 |
Why?
|
| Genes, Reporter | 4 | 2015 | 148 | 0.320 |
Why?
|
| Autophagy | 1 | 2011 | 140 | 0.310 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 189 | 0.310 |
Why?
|
| Coculture Techniques | 3 | 2014 | 109 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2010 | 257 | 0.270 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 11 | 0.270 |
Why?
|
| Membrane Proteins | 3 | 2010 | 561 | 0.260 |
Why?
|
| Animals | 11 | 2015 | 16992 | 0.250 |
Why?
|
| Repressor Proteins | 1 | 2007 | 273 | 0.220 |
Why?
|
| Deoxyribonuclease I | 3 | 2015 | 26 | 0.210 |
Why?
|
| Heterochromatin | 1 | 2004 | 19 | 0.210 |
Why?
|
| Hypersensitivity | 1 | 2022 | 32 | 0.190 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 17 | 0.180 |
Why?
|
| Genes, Immunoglobulin | 1 | 2001 | 37 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 1869 | 0.180 |
Why?
|
| Humans | 12 | 2022 | 43102 | 0.160 |
Why?
|
| Cell Line | 2 | 2014 | 1410 | 0.160 |
Why?
|
| Sequence Deletion | 2 | 2015 | 93 | 0.160 |
Why?
|
| Cells, Cultured | 2 | 2014 | 1621 | 0.150 |
Why?
|
| Chromatin | 2 | 2015 | 186 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 152 | 0.150 |
Why?
|
| Lymphoid Tissue | 2 | 2010 | 19 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2021 | 549 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 278 | 0.120 |
Why?
|
| Blotting, Northern | 2 | 2007 | 150 | 0.120 |
Why?
|
| Transgenes | 2 | 2007 | 65 | 0.120 |
Why?
|
| Poverty | 1 | 2018 | 400 | 0.110 |
Why?
|
| DNA Footprinting | 2 | 2007 | 8 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2014 | 37 | 0.100 |
Why?
|
| Immune System | 1 | 2014 | 41 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2004 | 6 | 0.100 |
Why?
|
| Random Allocation | 1 | 2013 | 147 | 0.100 |
Why?
|
| Eosinophils | 2 | 2022 | 24 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2010 | 411 | 0.090 |
Why?
|
| Radiation Chimera | 1 | 2011 | 8 | 0.090 |
Why?
|
| HLA-B7 Antigen | 1 | 2010 | 2 | 0.090 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 15 | 0.090 |
Why?
|
| Base Sequence | 2 | 2004 | 983 | 0.080 |
Why?
|
| Methylation | 1 | 2010 | 119 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 333 | 0.080 |
Why?
|
| Lysine | 1 | 2010 | 119 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2005 | 1271 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 204 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 1542 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 69 | 0.080 |
Why?
|
| Histones | 1 | 2010 | 197 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 526 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2004 | 735 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1035 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 54 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.060 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2005 | 2 | 0.060 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 42 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2005 | 141 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 64 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 64 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2004 | 183 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2004 | 168 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 244 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 532 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2022 | 61 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 61 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2004 | 281 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2022 | 317 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 671 | 0.050 |
Why?
|
| RNA | 1 | 2004 | 266 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 92 | 0.040 |
Why?
|
| Child | 2 | 2020 | 3443 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 592 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 780 | 0.040 |
Why?
|
| Mutation | 1 | 2004 | 1177 | 0.040 |
Why?
|
| Male | 3 | 2018 | 23409 | 0.030 |
Why?
|
| Female | 3 | 2018 | 24698 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2019 | 182 | 0.030 |
Why?
|
| Health Surveys | 1 | 2018 | 405 | 0.030 |
Why?
|
| Florida | 1 | 2018 | 478 | 0.030 |
Why?
|
| Medicare | 1 | 2019 | 332 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1604 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2018 | 363 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 616 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 1234 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1546 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 1612 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2853 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 2544 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 3994 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 184 | 0.020 |
Why?
|
| United States | 1 | 2019 | 5205 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 279 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 6081 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 8214 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 12222 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1568 | 0.010 |
Why?
|